Court sides with FDA in tirzepatide shortage fight: 5 notes
The 5th U.S. Circuit Court of Appeals affirmed Aug. 27 that the FDA acted lawfully when it declared Eli Lilly’s tirzepatide shortage resolved, according to court documents reviewed by Becker’s The ruling delivers a defeat to compounding pharmacies that had sued to keep making cheaper, unapproved versions of Mounjaro and Zepbound. Here are five things […] The post Court sides with FDA in tirzepatide shortage fight: 5 notes appeared first on Becker's Hospital Review | Health...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.